Table 3.
Univariable analysis | ||
---|---|---|
Odds Ratio |
95% Confidence Interval |
|
Guideline-recommended vancomycin dosing | 0.70 | 0.32–1.58 |
Pitt Bacteremia Score of 4 or greater | 1.80 | 0.86–3.78 |
Concomittantnephrotoxins (aminoglycosides, intravenous contrast, vasopressors) |
1.38 | 0.64–2.97 |
Weight of 100kg or greater | 1.53 | 0.66–3.56 |
Age greater than 65 years | 2.91 | 1.36–6.27 |
Vancomycin trough concentration greater than 15 mg/dl | 2.03 | 0.91–4.56 |
Development of nephrotoxicity | 3.59 | 1.67–7.74 |
Multivariable analysis | ||
Odds Ratio |
95% Confidence Interval |
|
Guideline-recommended vancomycin dosing | 0.54 | 0.22–1.36 |
Development of nephrotoxicity | 2.87 | 1.21–6.78 |
Pitt Bacteremia Score of 4 or greater | 2.94 | 1.05–8.22 |
Age greater than 65 years | 2.50 | 1.03–6.07 |